Selective inhibition by ketanserin and spiroperidol of 5-HT-induced myometrial contractionICHIDA, S; HAYASHI, T; TERAO, M et al.European journal of pharmacology. 1983, Vol 96, Num 1-2, pp 155-158, issn 0014-2999Article

Fluorine-18-N-methylspiroperidol: radiolytic decomposition as a consequence of high specific activity and high dose levelsMACGREGOR, R. R; SCHLYER, D. J; FOWLER, J. S et al.Journal of nuclear medicine. 1987, Vol 28, Num 1, pp 60-67, issn 0097-9058Article

The effect of spiroperidol on tonic immobility in domestic fowlHENNIG, C. W; SPENCER, B. D.Bulletin of the Psychonomic Society. 1983, Vol 21, Num 4, pp 317-320, issn 0090-5054Article

[³H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D₄ receptorMORELAND, Robert B; TERRANOVA, Marc A; CHANG, Renjie et al.European journal of pharmacology. 2004, Vol 497, Num 2, pp 147-154, issn 0014-2999, 8 p.Article

Computer-assisted video analysis of [³H] spiroperidol binding autoradiographsALTAR, C. A; WALTER, R. J. JR; NEVE, K. A et al.Journal of neuroscience methods. 1984, Vol 10, Num 3, pp 173-188, issn 0165-0270Article

Temperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [³H] spiperone binding to rat cortical membranes: regulation by guanine nucleotide and antidepressant treatmentKENDALL, D. A; NAHORSKI, S. R.The Journal of pharmacology and experimental therapeutics. 1983, Vol 227, Num 2, pp 429-434, issn 0022-3565Article

Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPSKILPATRICK, G. J; JENNER, P; MARSDEN, C. D et al.Journal of pharmacy and pharmacology. 1985, Vol 37, Num 5, pp 320-328, issn 0022-3573Article

Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decorticationVAN DER WERF, J. F; VAN HET SCHIP, F; SEBENS, J. B et al.European journal of pharmacology. 1984, Vol 102, Num 3-4, pp 387-399, issn 0014-2999Article

The effect of cholecystokinin octapeptide on rat striatal ³H spiperone bindingÓSHAUGHNESSY, C; POAT, J. A; TURNBULL, M. J et al.Biochemical pharmacology. 1985, Vol 34, Num 15, pp 2675-2677, issn 0006-2952Article

Trapping of labelled ligands in intact cells: a pitfall in binding studiesMALOTEAUX, J.-M; GOSSUIN, A; WATERKEYN, C et al.Biochemical pharmacology. 1983, Vol 32, Num 17, pp 2543-2548, issn 0006-2952Article

Differential effects of [³H]nemonapride and [³H]spiperone binding on human dopamine D₄ receptorsHIDAKA, K; MATSUMOTO, M; TADA, S et al.Neuroscience letters. 1995, Vol 186, Num 2-3, pp 145-148, issn 0304-3940Article

In vivo binding of spiroperidol and bromospiroperidol at low drug loadingsDEJESUS, O. T; REVENAUGH, J. R; DINERSTEIN, R. J et al.Life sciences (1973). 1984, Vol 35, Num 21, pp 2165-2168, issn 0024-3205Article

Autoradiographic mapping of spirodecanone binding-sites in the hippocampal region of the rat. Evidence for a localization on intrinsic neuronsKOHLER, C.Neuroscience letters. 1984, Vol 46, Num 2, pp 179-184, issn 0304-3940Article

Evidence for an increase in [³H] spiperone binding in hypothalamic nuclei during the development of spontaneous hypertension in the ratLE FUR, G; GUILLOUX, F; UZAN, A et al.Clinical and experimental hypertension. Part A, Theory and practice. 1983, Vol 5, Num 9, pp 1537-1542, issn 0730-0077Article

Non-competitive interaction between raclopride and spiperone on human D_2L-receptors in intact Chinese hamster ovary cellsPACKEU, Ann; DE BACKER, Jean-Paul; VAUQUELIN, Georges et al.Fundamental & clinical pharmacology. 2010, Vol 24, Num 3, pp 283-291, issn 0767-3981, 9 p.Article

Functional coupling of the human dopamine D₂ receptor with Gα_i1, Gα_i2, Gα_i3 and Gα_oG proteins: evidence for agonist regulation of G protein selectivityGAZI, Lucien; NICKOLLS, Sarah A; STRANGE, Philip G et al.British journal of pharmacology. 2003, Vol 138, Num 5, pp 775-786, issn 0007-1188, 12 p.Article

In vitro pharmacological profile of 3-N-(2-fluoroethyl)spiperoneGOFFINET, A. M; LEYSEN, J; LABAR, D et al.Journal of cerebral blood flow and metabolism. 1990, Vol 10, Num 1, pp 140-142, issn 0271-678XArticle

THERMODYNAMIC DIFFERENCES BETWEEN AGONIST AND ANTAGONIST INTERACTIONS WITH BINDING SITES FOR (^U3H)SPIROPERIDOL IN RAT STRIATUMZAHNISER NR; MOLINOFF PB.1983; MOLECULAR PHARMACOLOGY; ISSN 0026-895X; USA; DA. 1983; VOL. 23; NO 2; PP. 303-309; BIBL. 26 REF.Article

POSTNATAL DEVELOPMENT OF DOPAMINERGIC AND CHOLINERGIC CATALEPSY IN THE RATBAEZ LA; ESKRIDGE NK; SCHEIN R et al.1976; EUROP. J. PHARMACOL.; NETHERL.; DA. 1976; VOL. 36; NO 1; PP. 155-162; BIBL. 24 REF.Article

Do antipsychotic drugs and serotonin down regulate [³H]-spiroperidol binding sites in human cortex?ANDORN, A. C.Life sciences (1973). 1986, Vol 38, Num 14, pp 1251-1260, issn 0024-3205Article

Anodic voltammetry of butyrophenone neurolepticsBISHOP, E; HUSSEIN, W.Analyst (London. 1877. Print). 1984, Vol 109, Num 2, pp 139-141, issn 0003-2654Article

Cations decrease specific [³H]-spiroperidol binding in human prefrontal cortexHUANG, E. H; PICKETT, J. M; SIEGAL, J. D et al.Life sciences (1973). 1986, Vol 38, Num 15, pp 1369-1373, issn 0024-3205Article

Decreased [³H]spiperone binding in the anterior cingulate cortex of schizophrenia patients: An autoradiographic studyZAVITSANOU, K; HUANG, X. F.Neuroscience. 2002, Vol 109, Num 4, pp 709-716, issn 0306-4522Article

Elevated lymphocyte spiperone binding : A vulnerability factor for affective psychosis?FARTACEK, R; GERETSEGGER, C; BREITFUSS, A et al.Biological psychiatry (1969). 1997, Vol 41, Num 1, pp 107-110, issn 0006-3223Article

Methodology of ³H-spiperone binding to lymphocytesBONDY, B; ACKENHEIL, M; ENGEL, R. R et al.Journal of psychiatric research. 1990, Vol 24, Num 1, pp 83-92, issn 0022-3956, 10 p.Article